| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YRTPH.2011.11.013 |
| P698 | PubMed publication ID | 22178170 |
| P50 | author | Sean W Linder | Q108620700 |
| P2093 | author name string | Carl E Cerniglia | |
| S Steve Yan | |||
| Silvia A Pineiro | |||
| Youngbeom Ahn | |||
| Brian T Veach | |||
| A Haydée Fernández | |||
| P2860 | cites work | Diversity of the human intestinal microbial flora | Q24544241 |
| Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
| MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0 | Q26778434 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Towards the human intestinal microbiota phylogenetic core | Q28251918 | ||
| The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
| Monitoring of fluoroquinolone residual levels in chicken eggs by microbiological assay and confirmation by liquid chromatography | Q33294417 | ||
| Gastrointestinal microbiology enters the metagenomics era. | Q33307488 | ||
| The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities | Q33361423 | ||
| Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing | Q33385985 | ||
| A high-throughput DNA sequence aligner for microbial ecology studies | Q33518563 | ||
| The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer. | Q33549951 | ||
| Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora | Q33675379 | ||
| Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era | Q33939802 | ||
| Assembly of the human intestinal microbiota | Q33997399 | ||
| Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans | Q34097864 | ||
| Transformation of the antibacterial agent norfloxacin by environmental mycobacteria | Q35023629 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Reductive dehalogenation of brominated phenolic compounds by microorganisms associated with the marine sponge Aplysina aerophoba | Q35154893 | ||
| Norfloxacin binds to human fecal material | Q35566005 | ||
| Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora | Q36048706 | ||
| Impact of antimicrobial residues on gut communities: are the new regulations effective? | Q36797303 | ||
| Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. | Q39470224 | ||
| Binding of aminoglycosides to feces | Q41030610 | ||
| Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces | Q42112052 | ||
| Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant | Q43367661 | ||
| Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. | Q44210229 | ||
| A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces | Q44841789 | ||
| Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi | Q46641217 | ||
| Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora | Q46675684 | ||
| Antibiotic residues distribute uniformly in broiler chicken breast muscle tissue | Q46781191 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Co-amendment with halogenated compounds enhances anaerobic microbial dechlorination of 1,2,3,4-tetrachlorodibenzo-P-dioxin and 1,2,3,4-tetrachlorodibenzofuran in estuarine sediments | Q46883398 | ||
| Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model | Q50082656 | ||
| The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. | Q51211577 | ||
| The non-enzymatic inactivation of thirteen β-lactam antibiotics in human faeces | Q52411505 | ||
| The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animals. | Q53355666 | ||
| Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. | Q54302049 | ||
| Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. | Q54602240 | ||
| High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue | Q69385867 | ||
| Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination | Q70279915 | ||
| Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract | Q70736444 | ||
| Determinants of decreased fecal consistency in patients with diarrhea | Q72281860 | ||
| Microbial models of soil metabolism: biotransformations of danofloxacin | Q74126747 | ||
| Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography--tandem mass spectrometry | Q79421611 | ||
| Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria | Q80319258 | ||
| Simultaneous determination of (fluoro)quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA) | Q83141775 | ||
| The relationship between blood and muscle samples to monitor for residues of the antibiotic enrofloxacin in chickens | Q83239742 | ||
| A new method for chemical analysis of faeces | Q93645679 | ||
| P433 | issue | 1 | |
| P921 | main subject | feces | Q496 |
| P304 | page(s) | 74-84 | |
| P577 | publication date | 2011-12-09 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | In vitro enrofloxacin binding in human fecal slurries | |
| P478 | volume | 62 |
| Q26850895 | Alternative strategies for proof-of-principle studies of antibacterial agents |
| Q38904469 | An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome |
| Q91509098 | In vitro test systems to determine tetracycline residue binding to human feces |
| Q36683404 | Influence of Sterilized Human Fecal Extract on the Sensitivity of Salmonella enterica ATCC 13076 and Listeria monocytogenes ATCC 15313 to Enrofloxacin |
Search more.